Differential phenotypic and functional profile of epitope-specific cytotoxic CD8+ T cells in benznidazole-treated chronic asymptomatic Chagas disease patients
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1866 (3) , 165629
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
- Ministerio de Economía y Competitividad
This publication has 42 references indexed in Scilit:
- Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas diseaseRevista do Instituto de Medicina Tropical de São Paulo, 2013
- Risk Factors and Primary Prevention of Congenital Chagas Disease in a Nonendemic CountryClinical Infectious Diseases, 2012
- Depletion of Tregs for Adoptive T-cell Therapy Using CD44 and CD137 as Selection MarkersImmunotherapy, 2012
- Characterization of an Immunodominant Antigenic Epitope from Trypanosoma cruzi as a Biomarker of Chronic Chagas' Disease PathologyClinical and Vaccine Immunology, 2012
- Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markersBMC Infectious Diseases, 2011
- Frequency of specific CD8+ T cells for a promiscuous epitope derived from Trypanosoma cruzi KMP-11 protein in chagasic patientsParasite Immunology, 2010
- Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment EfficacyClinical Infectious Diseases, 2009
- CD8+ T cells in Trypanosoma cruzi infectionCurrent Opinion in Immunology, 2009
- High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infectionPLOS Neglected Tropical Diseases, 2008
- Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas diseaseNature Medicine, 2008